Key result
Higher admission INR is linked to ~38% lower odds of IV-tPA per 0.1-unit increase in AIS.
Why the study?
Sex-specific factors associated with intravenous thrombolysis (IV-tPA) use in acute ischemic stroke remain unclear among metabolically high-risk patients with hypertriglyceridemia (triglycerides ≥ 200 mg/dL).
What sex-specific clinical and functional factors are associated with in-hospital IV-tPA administration in acute ischemic stroke patients with hypertriglyceridemia?
Observational
What sex-specific clinical and functional factors are associated with in-hospital IV-tPA administration in acute ischemic stroke patients with hypertriglyceridemia?
In acute ischemic stroke patients with hypertriglyceridemia, IV-tPA administration is linked to sex-specific clinical and functional determinants, with elevated admission INR, prior TIA, and lack of discharge antithrombotics significantly reducing treatment odds in men.
Answers are grounded in this paper and cite their sources.
May inform eligibility review in men with AIS and hypertriglyceridemia; hypothesis-generating for sex-specific treatment disparities.
Background: Sex differences in intravenous thrombolysis (IV-tPA) use persist in acute ischemic stroke (AIS), but sex-specific factors associated with treatment remain unclear in metabolically high-risk patients. Hypertriglyceridemia (triglycerides [TGs] ≥ 200 mg/dL) may increase vascular and coagulation burden, yet its relationship with sex-specific IV-tPA use is uncertain. Methods: Sex-stratified multivariable logistic regression identified factors associated with in-hospital IV-tPA administration among male and female AIS patients with TGs ≥ 200 mg/dL. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUROC). Results: Among men, lower odds of IV-tPA administration were associated with higher admission international normalized ratio (INR) (odds ratio [OR] per 0.1-unit increase, 0.62; 95% confidence interval [CI], 0.40–0.93), prior transient ischemic attack (OR, 0.239; 95% CI, 0.069–0.830), and absence of antithrombotic therapy at discharge (OR, 0.014; 95% CI, 0.003–0.068). Among women, higher INR showed a borderline, imprecise inverse association with treatment. Baseline ambulatory-status categories were associated with treatment receipt. AUROC was 0.882 in men and 0.862 in women. Conclusions: IV-tPA administration among AIS patients with hypertriglyceridemia was associated with sex-specific clinical and functional factors. Higher INR was associated with lower treatment odds in both sexes, although the female estimate was imprecise.
No takes yet. Share an insight, caveat, or question.
Nathaniel et al. (2026) conducted an observational in Acute ischemic stroke with hypertriglyceridemia (triglycerides ≥ 200 mg/dL). Clinical and functional risk factors (admission INR, prior TIA, absence of discharge antithrombotic therapy, baseline ambulatory status) vs. Female versus male sex strata was evaluated on In-hospital intravenous thrombolysis (IV-tPA) administration (OR 0.62, 95% CI 0.40-0.93). Higher admission INR and prior TIA were associated with lower odds of IV-tPA administration in men with AIS.
Synapse has enriched 10 related papers. Consider them for comparative context: